| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.949 | 0 | 0.976 | 5 Hydroxytryptamine 4 agonist | 0.827 0.001 DBMET02197 0.301 0.001 DBMET02199 0.052 0.003 DBMET02200 0.976 0 DBMET02201 0.445 0.001 DBMET02202 0.689 0.001 DBMET02203 0.475 0.001 DBMET02198 | DBMET02201 | |
| 0.86 | 0.001 | 0.86 | 5 Hydroxytryptamine 4 antagonist | 0.789 0.001 DBMET02197 0.271 0.002 DBMET02199 0.087 0.01 DBMET02200 0.307 0.002 DBMET02201 0.362 0.002 DBMET02202 0.577 0.001 DBMET02203 0.58 0.001 DBMET02198 | ||
| 0.776 | 0.004 | 0.776 | 5 Hydroxytryptamine antagonist | 0.672 0.004 DBMET02197 0.346 0.014 DBMET02199 0.443 0.009 DBMET02201 0.291 0.02 DBMET02202 0.726 0.004 DBMET02203 0.363 0.013 DBMET02198 | ||
| 0.738 | 0.004 | 0.865 | 5 Hydroxytryptamine agonist | 0.71 0.004 DBMET02197 0.34 0.007 DBMET02199 0.079 0.042 DBMET02200 0.715 0.004 DBMET02201 0.544 0.004 DBMET02202 0.865 0.003 DBMET02203 0.657 0.004 DBMET02198 | DBMET02203 | |
| 0.549 | 0.003 | 0.794 | 5 Hydroxytryptamine 3 antagonist | 0.441 0.003 DBMET02197 0.097 0.018 DBMET02199 0.312 0.004 DBMET02201 0.145 0.01 DBMET02202 0.794 0.002 DBMET02203 0.318 0.004 DBMET02198 | DBMET02203 | |
| 0.447 | 0.031 | 0.508 | Spasmolytic | 0.508 0.022 DBMET02197 0.216 0.108 DBMET02199 0.416 0.037 DBMET02200 0.499 0.023 DBMET02201 0.347 0.053 DBMET02202 0.359 0.05 DBMET02203 0.461 0.029 DBMET02198 | DBMET02197 | |
| 0.4 | 0.008 | 0.4 | Dopamine antagonist | 0.329 0.01 DBMET02197 0.076 0.05 DBMET02199 0.215 0.017 DBMET02201 0.201 0.019 DBMET02202 0.188 0.02 DBMET02203 0.1 0.038 DBMET02198 | ||
| 0.422 | 0.033 | 0.462 | Nootropic | 0.42 0.033 DBMET02197 0.433 0.031 DBMET02201 0.228 0.127 DBMET02202 0.462 0.025 DBMET02203 0.297 0.075 DBMET02198 | DBMET02203 | |
| 0.386 | 0.007 | 0.386 | Dopamine D2 antagonist | 0.296 0.01 DBMET02197 0.07 0.044 DBMET02199 0.147 0.023 DBMET02201 0.179 0.019 DBMET02202 0.165 0.02 DBMET02203 0.081 0.039 DBMET02198 | ||
| 0.416 | 0.078 | 0.519 | Analgesic | 0.425 0.074 DBMET02197 0.432 0.071 DBMET02201 0.519 0.044 DBMET02203 0.44 0.068 DBMET02198 | DBMET02203 | |
| 0.322 | 0.003 | 0.49 | 5 Hydroxytryptamine 3B antagonist | 0.246 0.003 DBMET02197 0.048 0.015 DBMET02199 0.071 0.008 DBMET02201 0.052 0.014 DBMET02202 0.49 0.002 DBMET02203 0.135 0.004 DBMET02198 | DBMET02203 | |
| 0.385 | 0.088 | 0.426 | 5 Hydroxytryptamine release inhibitor | 0.426 0.063 DBMET02197 0.291 0.176 DBMET02199 0.336 0.128 DBMET02200 0.276 0.194 DBMET02202 0.368 0.101 DBMET02203 0.359 0.107 DBMET02198 | DBMET02197 | |
| 0.319 | 0.044 | 0.594 | HERG channel blocker | 0.276 0.056 DBMET02197 0.594 0.008 DBMET02201 0.146 0.135 DBMET02202 0.28 0.055 DBMET02203 | DBMET02201 | |
| 0.306 | 0.048 | 0.556 | Potassium channel (Voltage-sensitive) blocker | 0.257 0.064 DBMET02197 0.556 0.01 DBMET02201 0.264 0.061 DBMET02203 | DBMET02201 | |
| 0.257 | 0.003 | 0.367 | 5 Hydroxytryptamine 3A antagonist | 0.187 0.004 DBMET02197 0.087 0.025 DBMET02199 0.091 0.022 DBMET02201 0.075 0.036 DBMET02202 0.367 0.003 DBMET02203 0.142 0.005 DBMET02198 | DBMET02203 | |
| 0.259 | 0.065 | 0.259 | 5 Hydroxytryptamine 1E antagonist | 0.208 0.122 DBMET02197 0.251 0.074 DBMET02203 | ||
| 0.292 | 0.116 | 0.381 | Toll-Like receptor agonist | 0.323 0.097 DBMET02197 0.213 0.186 DBMET02199 0.3 0.111 DBMET02203 0.381 0.068 DBMET02198 | DBMET02198 | |
| 0.29 | 0.117 | 0.381 | Toll-Like receptor 7 agonist | 0.321 0.098 DBMET02197 0.216 0.182 DBMET02199 0.302 0.109 DBMET02203 0.381 0.068 DBMET02198 | DBMET02198 | |
| 0.242 | 0.113 | 0.242 | Ca(v)3.3 blocker | 0.228 0.137 DBMET02197 0.209 0.172 DBMET02199 0.208 0.175 DBMET02198 | ||
| 0.155 | 0.043 | 0.155 | 5 Hydroxytryptamine 2 antagonist | 0.104 0.069 DBMET02197 0.098 0.073 DBMET02203 | ||
| 0.128 | 0.019 | 0.128 | Dopamine D3 antagonist | 0.092 0.027 DBMET02197 0.078 0.034 DBMET02201 0.087 0.029 DBMET02202 0.054 0.051 DBMET02203 | ||
| 0.192 | 0.098 | 0.425 | Potassium channel blocker | 0.153 0.132 DBMET02197 0.425 0.019 DBMET02201 | DBMET02201 | |
| 0.114 | 0.04 | 0.114 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.194 | 0.124 | 0.221 | Cardiotonic | 0.17 0.152 DBMET02197 0.221 0.102 DBMET02201 | DBMET02201 | |
| 0.109 | 0.045 | 0.113 | Glutamate (mGluR7) agonist | 0.107 0.047 DBMET02203 0.113 0.038 DBMET02198 | DBMET02198 | |
| 0.124 | 0.064 | 0.124 | Anesthetic local | |||
| 0.104 | 0.054 | 0.106 | Alpha adrenoreceptor antagonist | 0.079 0.072 DBMET02197 0.106 0.053 DBMET02201 | DBMET02201 | |
| 0.164 | 0.114 | 0.172 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.152 0.129 DBMET02197 0.172 0.103 DBMET02202 0.154 0.127 DBMET02203 | DBMET02202 | |
| 0.055 | 0.013 | 0.058 | DNA gyrase subunit A inhibitor | 0.057 0.011 DBMET02197 0.044 0.026 DBMET02199 0.041 0.033 DBMET02200 0.041 0.032 DBMET02201 0.058 0.011 DBMET02202 0.057 0.012 DBMET02203 0.052 0.015 DBMET02198 | DBMET02202 | |
| 0.086 | 0.05 | 0.1 | Alpha 1 adrenoreceptor antagonist | 0.1 0.043 DBMET02201 | DBMET02201 | |
| 0.107 | 0.075 | 0.107 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.08 | 0.049 | 0.097 | Alpha 2a adrenoreceptor antagonist | 0.097 0.038 DBMET02203 | DBMET02203 | |
| 0.157 | 0.126 | 0.157 | MAP kinase kinase 5 inhibitor | |||
| 0.13 | 0.1 | 0.13 | Neuropeptide Y1 antagonist | 0.125 0.111 DBMET02202 | ||
| 0.044 | 0.018 | 0.134 | Somatostatin 4 agonist | 0.045 0.018 DBMET02197 0.134 0.005 DBMET02203 0.043 0.02 DBMET02198 | DBMET02203 | |
| 0.104 | 0.078 | 0.104 | Acetylcholine release stimulant | |||
| 0.065 | 0.042 | 0.078 | DNA gyrase inhibitor | 0.066 0.041 DBMET02197 0.057 0.054 DBMET02200 0.058 0.052 DBMET02202 0.078 0.028 DBMET02203 0.071 0.035 DBMET02198 | DBMET02203 | |
| 0.165 | 0.144 | 0.165 | ErbB-1 antagonist | 0.164 0.146 DBMET02202 | ||
| 0.098 | 0.078 | 0.179 | 5 Hydroxytryptamine 3A agonist | 0.097 0.08 DBMET02197 0.179 0.022 DBMET02203 | DBMET02203 | |
| 0.07 | 0.051 | 0.086 | Alpha 1a adrenoreceptor antagonist | 0.086 0.042 DBMET02201 | DBMET02201 | |
| 0.044 | 0.026 | 0.064 | Alpha 1L adrenoreceptor agonist | 0.042 0.031 DBMET02197 0.041 0.034 DBMET02199 0.042 0.034 DBMET02201 0.064 0.007 DBMET02203 0.041 0.034 DBMET02198 | DBMET02203 | |
| 0.066 | 0.049 | 0.107 | Alpha adrenoreceptor agonist | 0.107 0.025 DBMET02203 | DBMET02203 | |
| 0.058 | 0.045 | 0.161 | Alpha 2 adrenoreceptor agonist | 0.054 0.051 DBMET02197 0.161 0.005 DBMET02203 | DBMET02203 | |
| 0.079 | 0.067 | 0.086 | Alpha 2 adrenoreceptor antagonist | 0.086 0.059 DBMET02203 | DBMET02203 | |
| 0.047 | 0.036 | 0.05 | CC chemokine receptor 2B antagonist | 0.05 0.032 DBMET02197 0.046 0.039 DBMET02198 | DBMET02197 | |
| 0.066 | 0.057 | 0.066 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.13 | 0.124 | 0.159 | Interleukin 6 antagonist | 0.159 0.077 DBMET02197 0.147 0.093 DBMET02203 0.146 0.096 DBMET02198 | DBMET02197 | |
| 0.023 | 0.017 | 0.023 | CC chemokine 8 receptor antagonist | 0.022 0.02 DBMET02203 | ||
| 0.048 | 0.045 | 0.052 | Acetylcholine muscarinic agonist | 0.052 0.041 DBMET02203 | DBMET02203 | |
| 0.066 | 0.065 | 0.156 | MAP-kinase-activated kinase 2 inhibitor | 0.156 0.009 DBMET02203 | DBMET02203 | |
| 0.072 | 0.076 | 0.167 | MAP-kinase-activated kinase inhibitor | 0.167 0.01 DBMET02203 | DBMET02203 | |
| 0.022 | 0.028 | 0.055 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.055 0.008 DBMET02203 0.026 0.022 DBMET02198 | DBMET02203 | |
| 0.017 | 0.024 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.014 DBMET02197 0.019 0.015 DBMET02203 | DBMET02203 | |
| 0.071 | 0.081 | 0.09 | Antiadrenergic | 0.09 0.062 DBMET02201 | DBMET02201 | |
| 0.068 | 0.081 | 0.088 | Adrenaline antagonist | 0.088 0.062 DBMET02201 | DBMET02201 | |
| 0.047 | 0.063 | 0.091 | 5 Hydroxytryptamine 2A agonist | 0.091 0.019 DBMET02203 | DBMET02203 | |
| 0.044 | 0.061 | 0.051 | CC chemokine 2 receptor antagonist | 0.051 0.043 DBMET02197 0.051 0.043 DBMET02203 | DBMET02203 | |
| 0.106 | 0.129 | 0.119 | Cholinergic | 0.119 0.108 DBMET02201 | DBMET02201 | |
| 0.095 | 0.12 | 0.165 | Sodium channel blocker | 0.165 0.047 DBMET02203 | DBMET02203 | |
| 0.062 | 0.088 | 0.077 | Adrenaline agonist | 0.077 0.062 DBMET02197 0.073 0.068 DBMET02203 | DBMET02197 | |
| 0.054 | 0.084 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.047 DBMET02197 0.06 0.051 DBMET02202 | DBMET02197 | |
| 0.07 | 0.105 | 0.096 | ATPase (Vacuolar H+) inhibitor | 0.096 0.045 DBMET02200 | DBMET02200 | |
| 0.063 | 0.099 | 0.081 | Acetylcholine agonist | 0.081 0.065 DBMET02203 | DBMET02203 | |
| 0.214 | 0.251 | 0.244 | Calcium channel L-type activator | 0.244 0.212 DBMET02202 | DBMET02202 | |
| 0.107 | 0.144 | 0.148 | MAP3K9 inhibitor | 0.148 0.064 DBMET02197 | DBMET02197 | |
| 0.068 | 0.114 | 0.09 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 DBMET02203 | DBMET02203 | |
| 0.052 | 0.101 | 0.169 | Phosphodiesterase IV inhibitor | 0.169 0.018 DBMET02201 0.087 0.055 DBMET02203 | DBMET02201 | |
| 0.016 | 0.072 | 0.033 | Somatostatin agonist | 0.033 0.02 DBMET02203 | DBMET02203 | |
| 0.028 | 0.086 | 0.046 | Poly(ADP-ribose) polymerase inhibitor | 0.046 0.029 DBMET02203 | DBMET02203 | |
| 0.007 | 0.07 | 0.02 | Cyclin T1 inhibitor | 0.02 0.01 DBMET02203 | DBMET02203 | |
| 0.005 | 0.074 | 0.025 | Microsomal triglyceride transfer protein inhibitor | 0.025 0.005 DBMET02201 | DBMET02201 | |
| 0.036 | 0.108 | 0.051 | Epithelial sodium channel blocker | 0.051 0.046 DBMET02203 | DBMET02203 | |
| 0.019 | 0.092 | 0.035 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.035 0.029 DBMET02203 | DBMET02203 | |
| 0.038 | 0.12 | 0.071 | 5 Hydroxytryptamine 3 agonist | 0.071 0.034 DBMET02203 | DBMET02203 | |
| 0.119 | 0.202 | 0.18 | Catenin beta inhibitor | 0.139 0.136 DBMET02203 0.18 0.052 DBMET02198 | DBMET02198 | |
| 0.027 | 0.115 | 0.04 | Integrin alpha1beta1 antagonist | 0.04 0.021 DBMET02198 | DBMET02198 | |
| 0.093 | 0.184 | 0.16 | NOS3 expression enhancer | 0.16 0.063 DBMET02200 0.121 0.113 DBMET02198 | DBMET02200 | |
| 0.07 | 0.164 | 0.098 | Hedgehog signaling inhibitor | 0.098 0.067 DBMET02203 | DBMET02203 | |
| 0.105 | 0.223 | 0.198 | ATPase inhibitor | 0.162 0.082 DBMET02199 0.198 0.039 DBMET02200 | DBMET02200 | |
| 0.063 | 0.181 | 0.108 | Toll-Like receptor 4 antagonist | 0.108 0.058 DBMET02200 | DBMET02200 | |
| 0.019 | 0.152 | 0.045 | Antibiotic Aminoglycoside-like | 0.045 0.017 DBMET02200 | DBMET02200 | |
| 0.1 | 0.233 | 0.14 | Lipocortins synthesis antagonist | 0.14 0.121 DBMET02198 | DBMET02198 | |
| 0.079 | 0.218 | 0.149 | Heat shock protein 90 antagonist | 0.149 0.076 DBMET02202 | DBMET02202 | |
| 0.067 | 0.207 | 0.121 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.121 0.105 DBMET02203 | DBMET02203 | |
| 0.082 | 0.224 | 0.137 | DNA methyltransferase I inhibitor | 0.137 0.12 DBMET02198 | DBMET02198 | |
| 0.044 | 0.19 | 0.173 | Bronchodilator | 0.173 0.024 DBMET02201 | DBMET02201 | |
| 0.057 | 0.205 | 0.083 | Hematopoietic | 0.083 0.065 DBMET02198 | DBMET02198 | |
| 0.052 | 0.202 | 0.159 | GABA C receptor rho-1 antagonist | 0.159 0.018 DBMET02203 | DBMET02203 | |
| 0.061 | 0.216 | 0.096 | Nav1.5 sodium channel blocker | 0.096 0.093 DBMET02203 | DBMET02203 | |
| 0.044 | 0.204 | 0.078 | Cell adhesion molecule inhibitor | 0.078 0.056 DBMET02198 | DBMET02198 | |
| 0.079 | 0.25 | 0.23 | Interleukin agonist | 0.23 0.095 DBMET02197 0.165 0.153 DBMET02203 0.211 0.11 DBMET02198 | DBMET02197 | |
| 0.024 | 0.197 | 0.061 | Check point kinase 1 inhibitor | 0.061 0.057 DBMET02203 | DBMET02203 | |
| 0.048 | 0.229 | 0.111 | AMP-activated protein kinase stimulant | 0.111 0.057 DBMET02200 | DBMET02200 | |
| 0.008 | 0.193 | 0.067 | 5 Hydroxytryptamine 2C agonist | 0.067 0.016 DBMET02203 | DBMET02203 | |
| 0.044 | 0.233 | 0.275 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.275 0.023 DBMET02201 | DBMET02201 | |
| 0.011 | 0.205 | 0.052 | 5 Hydroxytryptamine 2 agonist | 0.052 0.035 DBMET02203 | DBMET02203 | |
| 0.016 | 0.215 | 0.043 | 5 Hydroxytryptamine 2B agonist | 0.043 0.02 DBMET02203 | DBMET02203 | |
| 0.047 | 0.245 | 0.119 | Lipid peroxidase inhibitor | 0.119 0.094 DBMET02200 | DBMET02200 | |
| 0.041 | 0.253 | 0.174 | GABA C receptor antagonist | 0.174 0.02 DBMET02203 | DBMET02203 | |
| 0.023 | 0.243 | 0.061 | I kappa B kinase 2 inhibitor | 0.061 0.045 DBMET02203 | DBMET02203 | |
| 0.029 | 0.25 | 0.084 | I kappa B kinase inhibitor | 0.084 0.055 DBMET02203 | DBMET02203 | |
| 0.016 | 0.239 | 0.056 | Pim-2 kinase inhibitor | 0.056 0.035 DBMET02203 | DBMET02203 | |
| 0.05 | 0.291 | 0.104 | Cell adhesion inhibitor | 0.104 0.082 DBMET02198 | DBMET02198 | |
| 0.065 | 0.317 | 0.127 | GABA C receptor rho-2 antagonist | 0.127 0.111 DBMET02203 | DBMET02203 | |
| 0.018 | 0.283 | 0.051 | Lysine-specific demethylase 1A inhibitor | 0.051 0.044 DBMET02203 | DBMET02203 | |
| 0.024 | 0.309 | 0.089 | Pim-3 kinase inhibitor | 0.089 0.06 DBMET02203 | DBMET02203 | |
| 0.105 | 0.394 | 0.276 | Peptidyltransferase inhibitor | 0.164 0.16 DBMET02197 0.276 0.035 DBMET02200 | DBMET02200 | |
| 0.008 | 0.316 | 0.131 | Antineoplastic antibiotic | 0.131 0.035 DBMET02200 | DBMET02200 | |
| 0.06 | 0.368 | 0.413 | Tumour necrosis factor alpha release inhibitor | 0.193 0.115 DBMET02199 0.226 0.089 DBMET02200 0.413 0.025 DBMET02201 | DBMET02201 | |
| 0.045 | 0.366 | 0.382 | Immunostimulant | 0.382 0.055 DBMET02200 | DBMET02200 | |
| 0.039 | 0.365 | 0.117 | Diuretic | 0.117 0.109 DBMET02198 | DBMET02198 | |
| 0.039 | 0.365 | 0.447 | Angiogenesis stimulant | 0.447 0.016 DBMET02200 0.29 0.053 DBMET02202 | DBMET02200 | |
| 0.016 | 0.346 | 0.071 | Nitric oxide donor | 0.071 0.032 DBMET02200 | DBMET02200 | |
| 0.039 | 0.378 | 0.078 | Transcription factor NF kappa B stimulant | 0.078 0.075 DBMET02200 | DBMET02200 | |
| 0.013 | 0.353 | 0.048 | Protein 50S ribosomal subunit inhibitor | 0.048 0.042 DBMET02200 | DBMET02200 | |
| 0.01 | 0.35 | 0.143 | Selectin antagonist | 0.143 0.019 DBMET02200 | DBMET02200 | |
| 0.012 | 0.355 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.043 DBMET02200 | DBMET02200 | |
| 0.01 | 0.366 | 0.036 | Integrin alpha2 antagonist | 0.036 0.027 DBMET02203 | DBMET02203 | |
| 0.013 | 0.38 | 0.074 | Sphingosine 1-phosphate receptor 5 agonist | 0.074 0.015 DBMET02198 | DBMET02198 | |
| 0.101 | 0.475 | 0.267 | Interleukin 2 agonist | 0.205 0.18 DBMET02197 0.267 0.1 DBMET02200 0.228 0.145 DBMET02198 | DBMET02200 | |
| 0.046 | 0.435 | 0.238 | Antioxidant | 0.238 0.09 DBMET02200 | DBMET02200 | |
| 0.049 | 0.448 | 0.218 | Hepatoprotectant | 0.218 0.055 DBMET02200 | DBMET02200 | |
| 0.06 | 0.475 | 0.263 | Hypoglycemic | 0.263 0.069 DBMET02200 | DBMET02200 | |
| 0.038 | 0.466 | 0.136 | Platelet adhesion inhibitor | 0.136 0.124 DBMET02200 | DBMET02200 | |
| 0.036 | 0.484 | 0.154 | Nitric oxide antagonist | 0.154 0.092 DBMET02200 | DBMET02200 | |
| 0.075 | 0.531 | 0.214 | Apoptosis antagonist | 0.214 0.162 DBMET02200 | DBMET02200 | |
| 0.03 | 0.49 | 0.187 | Platelet antagonist | 0.187 0.111 DBMET02198 | DBMET02198 | |
| 0.08 | 0.584 | 0.455 | Antiinflammatory | 0.455 0.108 DBMET02200 | DBMET02200 | |
| 0.016 | 0.534 | 0.092 | GABA C receptor agonist | 0.092 0.076 DBMET02203 | DBMET02203 | |
| 0.082 | 0.646 | 0.202 | 5 Hydroxytryptamine uptake stimulant | 0.202 0.148 DBMET02203 | DBMET02203 | |
| 0.018 | 0.588 | 0.177 | Free radical scavenger | 0.177 0.117 DBMET02200 | DBMET02200 | |
| 0.034 | 0.608 | 0.236 | Immunosuppressant | 0.236 0.16 DBMET02200 | DBMET02200 | |
| 0.038 | 0.696 | 0.261 | Apoptosis agonist | 0.261 0.203 DBMET02200 | DBMET02200 | |
| 0.029 | 0.737 | 0.288 | Cyclophilin D inhibitor | 0.288 0.174 DBMET02200 | DBMET02200 | |
| 0.014 | 0.763 | 0.275 | Antibacterial | 0.275 0.154 DBMET02200 | DBMET02200 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |